- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Thousand Oaks Today
By the People, for the People
Wealth Enhancement Advisory Services Trims Stake in Amgen
Institutional investor reduces holdings in biotech giant Amgen by 5.6% in Q4 2025
Mar. 22, 2026 at 11:39am
Got story updates? Submit your updates here. ›
Wealth Enhancement Advisory Services LLC, a major institutional investor, reduced its stake in Amgen Inc. (NASDAQ:AMGN) by 5.6% during the fourth quarter of 2025, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 378,221 shares of the medical research company's stock, valued at $125,859,000.
Why it matters
Amgen is a leading biotechnology company and a major player in the pharmaceutical industry. Changes in institutional ownership of Amgen's stock can provide insights into market sentiment and investor confidence in the company's future prospects.
The details
According to the 13F filing, Wealth Enhancement Advisory Services sold 22,365 shares of Amgen during the fourth quarter, reducing its total holdings to 378,221 shares. The firm now owns approximately 0.07% of Amgen's outstanding stock. The move comes as Amgen's share price has fluctuated in recent months, with the stock trading between a 52-week low of $261.43 and a high of $391.29.
- Wealth Enhancement Advisory Services filed its 13F report for the fourth quarter of 2025 on March 22, 2026.
The players
Wealth Enhancement Advisory Services LLC
A major institutional investment firm that manages a diversified portfolio of assets, including a significant stake in Amgen Inc.
Amgen Inc.
A global biotechnology company that focuses on discovering, developing, manufacturing, and delivering human therapeutics to address serious illnesses.
The takeaway
The reduction in Wealth Enhancement Advisory Services' stake in Amgen suggests that the firm may be taking a more cautious approach to the biotech sector, or that it sees better investment opportunities elsewhere. However, Amgen remains a significant holding in the firm's portfolio, indicating that it still sees long-term value in the company.
